Cardiovascular Diabetology

JANUARY 8, 2024

Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Myocardial Infarction Kidney Disease Diabetes 105

Cardiovascular Diabetology

AUGUST 15, 2024

Diabetes mellitus (DM) and coronary microvascular dysfunction (CMD) increase the risk of adverse cardiac events in patients with non-ST-segment elevation myocardial infarction (NSTEMI). This study aimed to eva.

Myocardial Infarction 59

Myocardial Infarction Diabetes Research 59

Cardiovascular Diabetology

JANUARY 5, 2025

Inflammatory diseases impair the reparative properties of endothelial progenitor cells (EPC); however, the involvement of diabetes in EPC dysfunction associated with myocardial infarction (MI) remains unknown.

Myocardial Infarction 52

Myocardial Infarction Diabetes Research 52

Cardiovascular Diabetology

JANUARY 21, 2024

It is well-known that systemic inflammation plays a crucial role in the pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune-inflammation index (SII, platelet × neutrophil/lymph.

Myocardial Infarction 72

Myocardial Infarction Diabetes Research 72

Med Page Today

FEBRUARY 14, 2025

(MedPage Today) -- The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors, a prespecified.

Kidney Disease 81

Kidney Disease Heart Attack Heart attacks Diabetes 81

Cardiovascular Diabetology

JANUARY 21, 2025

The impact of sodiumglucose cotransporter-2 (SGLT2) inhibitors on mortality following myocardial infarction (MI) remains uncertain. Additionally, the role of type 2 diabetes mellitus (T2DM) and heart failure.

Myocardial Infarction 64

Myocardial Infarction Heart Failure Diabetes Research 64

Cardiovascular Diabetology

OCTOBER 29, 2024

Type 2 diabetes has traditionally been a risk factor for worse prognosis after myocardial infarction (MI), but major advances have been made in its treatment, and the use of secondary preventive measures has i.

Myocardial Infarction 52

Myocardial Infarction Diabetes Risk Factors Research 52

The New England Journal of Medicine

MAY 29, 2024

A 70-year-old woman with diabetes presented with epigastric pain and vomiting. ECG showed normal sinus rhythm with pathologic Q waves and T-wave inversions in the anterior leads. Ventriculography and echocardiography are shown in videos.

Myocardial Infarction 67

Myocardial Infarction Diabetes 67

Journal of the American Heart Association

DECEMBER 24, 2024

The primary outcome was atherothrombotic major adverse cardiovascular events as a composite outcome of cardiovascular mortality, nonfatal stroke, and nonfatal myocardial infarction. Patients were propensity matched in a 1:1 ratio using a caliper distance of 0.2 without replacement.

Diabetes 75

Diabetes Myocardial Infarction Outcomes Stroke 75

Cardiovascular Diabetology

JANUARY 5, 2024

Few studies explored the effect of the combination of glucose sodium-cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) on the incidence of cardiovascular events in pa.

Myocardial Infarction 106

Myocardial Infarction Diabetes Research 106

Cardiovascular Diabetology

FEBRUARY 17, 2025

We aimed to develop and validate prediction models for stroke and myocardial infarction (MI) in pati. Digitalization and big health system data open new avenues for targeted prevention and treatment strategies.

Myocardial Infarction 52

Myocardial Infarction Stroke Strokes Diabetes 52

Hypertension Journal

FEBRUARY 22, 2024

years for women with type 2 diabetes. 1.29) for women with type 2 diabetes.CONCLUSIONS:In women with diabetes, a history of hypertensive disorders of pregnancy was associated with an increased risk of incident cardiovascular disease and should be considered as a risk enhancer. years for women with type 1 and 29.8

Cardiovascular Disease 74

Cardiovascular Disease Hypertension Diabetes Myocardial Infarction 74

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time to first event (MI, stroke.

Heart Attack 76

Heart Attack Heart attacks Myocardial Infarction Diabetes 76

Cardiovascular Diabetology

JULY 9, 2024

To adapt risk prediction equations for myocardial infarction (MI), stroke, and heart failure (HF) among patients with type 2 diabetes in real-world settings using cross-institutional electronic health records.

Myocardial Infarction 52

Myocardial Infarction Diabetes Heart Failure Outcomes 52

European Journal of Heart Failure

JANUARY 14, 2025

The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.

Myocardial Infarction 40

Myocardial Infarction Bicuspid/Mitral Cardiogenic Shock Risk Factors 40

Circulation

NOVEMBER 11, 2024

eGC shedding could contribute to atherosclerotic plaque vulnerability and acute myocardial infarction (AMI) installation. The integrity of this structure sustains some vascular properties such as shear stress-induced nitric oxide release and the prevention of platelets and neutrophils adhesion on the vessel surface. The PBR [1.96±0.22µm

Myocardial Infarction 40

Myocardial Infarction Plaque Technology Diabetes 40

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundMicrovascular obstruction (MVO) and intramyocardial hemorrhage (IMH) are well‐established imaging biomarkers of failed myocardial tissue reperfusion in patients with ST‐segment elevation–myocardial infarction treated with percutaneous coronary intervention. Median culprit lesion vessel size was 3.1 (2.7–3.6)

Myocardial Infarction 40

Myocardial Infarction Thrombolysis Biomarkers Hemorrhage 40

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

They have a greater prevalence of obesity, dyslipidemia, metabolic syndrome and diabetes mellitus. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. Am J Phys Med Rehabil. 2023.12.010.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure 40

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

Meta-regression revealed type 2 diabetes mellitus and follow-up time influencing short-term mortality and CPC 1–2 at discharge, respectively.ConclusionEarly CAG in post-cardiac arrest patients without ST elevation is associated with long-term clinical benefits, particularly evident in observational studies.

Cardiac Arrest 59

Cardiac Arrest Myocardial Infarction Hospital Diabetes 59

DAIC

FEBRUARY 29, 2024

12:15 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Coronary Artery Disease Journal

JANUARY 11, 2024

Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. They had significantly lower rates of diabetes and hypertension and higher rates of male gender and smoking compared to the older group.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

Coronary Artery Disease Journal

APRIL 24, 2024

Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 40

Myocardial Infarction STEMI Diabetes Hypertension 40

Stroke Journal

FEBRUARY 1, 2024

We utilized a multi-state database to examine myocardial infarction (MI) risk post stroke or CAD to estimate cardiovascular complication risk.Method:We analyzed State Inpatient Database from New York (2011-2017) and Florida (2011-2019). Stroke, Volume 55, Issue Suppl_1 , Page AWP244-AWP244, February 1, 2024. 2.06, P = 0.60) (Figure).

Myocardial Infarction 40

Myocardial Infarction Inpatient Stroke Strokes 40

American College of Cardiology

APRIL 7, 2024

Edetate disodium-based chelation does not lead to improved outcomes in patients with diabetes who had previously suffered a myocardial infarction (MI), according to the results of the TACT2 study, presented during a Late-Breaking Clinical Trial session.

Myocardial Infarction 52

Myocardial Infarction Outcomes Diabetes Article 52

American College of Cardiology

APRIL 7, 2024

The goal of the TACT2 trial was to determine the potential clinical benefit of the chelating agent edetate disodium (EDTA) in older adults with a history of myocardial infarction (MI) and diabetes mellitus (DM).

Myocardial Infarction 49

Myocardial Infarction Diabetes Article 49

Dr. Smith's ECG Blog

SEPTEMBER 5, 2024

This is a value typical for a large subacute MI, n ormal value 48 hours after myocardial infarction is associated with Post-Infarction Regional Pericarditis ( PIRP ). Mechanical complications secondary to myocardial infarction are infrequent due to most patients receiving revascularization quite rapidly.

Cardiogenic Shock 109

Cardiogenic Shock Chest Pain Pericarditis Myocardial Infarction 109

Journal of Cardiovascular Pharmacology

JUNE 24, 2024

Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a novel class of anti-diabetic medications which have proved capable of providing breakthrough cardiovascular benefits in a variety of clinical scenarios, including patients with heart failure or obesity, irrespective of diabetic status.

Myocardial Infarction 40

Myocardial Infarction Heart Failure Pharmacology Diabetes 40

Circulation

NOVEMBER 11, 2024

Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To

Diabetes 40

Diabetes Blood Pressure Myocardial Infarction Kidney Disease 40

Heart BMJ

MAY 10, 2024

Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction. Arrhythmia prediction models have long relied on conventional risk factors such as age, diabetes, hypertension, and history of myocardial infarction and heart failure.

Arrhythmia 40

Arrhythmia Myocardial Infarction Atrial Fibrillation Heart Failure 40

Journal of the American Heart Association

MARCH 21, 2025

Patients were stratified according to polygenic risk score tertiles and observed for the occurrence of ischemic stroke or systemic embolism, myocardial infarction, and heart failure hospitalization. P=0.422) for myocardial infarction, and 1.02 (95% CI, 0.781.34;P=0.895) During a median followup of 4.6

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Embolism Stroke 40

Open Heart

JUNE 5, 2024

Background There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). vs 3.9%, p<0.001) and ST-elevation myocardial infarction (59.1% vs 9.9%, p=0.029).

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

However, due to the distinct biological functions of ASCs from different origins or donors with varing health statuses (such as aging, diabetes, or atherosclerosis), the heterogeneity of ASCs deserves more attention. Exosomes from ASCs also play an indispensable role in this process.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

Journal of Cardiovascular Pharmacology

NOVEMBER 6, 2023

Abstract: Aim of our systematic review and meta-analysis is to compare shortened (≤3 months) dual antiplatelet therapy (DAPT) with longer DAPT in diabetic patients undergoing percutaneous coronary interventions (PCI). Thus, S-DAPT could be considered as a safe and feasible option in diabetic patients. All rights reserved.

Diabetes 40

Diabetes Myocardial Infarction Thrombosis Stents 40

Journal of the American Heart Association

MARCH 21, 2025

CIMT but not carotid distensibility was associated with incident myocardial infarction. ConclusionsLower carotid distensibility and higher CIMT were associated with an increased risk of incident HF, despite adjustment for incident myocardial infarction.

Heart Failure 40

Heart Failure Myocardial Infarction Arrhythmia Diabetes 40

Journal of the American Heart Association

FEBRUARY 16, 2024

HRs for major adverse cardiovascular events, myocardial infarction, and stroke became less efficacious (ΔHR, −15% to −34%), with more weight loss for SGLT2i but not for GLP‐1RA trials (ΔHR, 4%−7%;Pinteraction&lt;0.05).

Blood Pressure 45

Blood Pressure Outcomes Diabetes Myocardial Infarction 45

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

Among those, 58% had diabetes, 50% had myocardial infarction, and 91% were in use of statin and aspirin. Analysis of inflammatory biomarkers and coronary CTA was also performed at baseline and 4 weeks after treatment. Results Forty patients aged 65.6 ± 8 years, 20 in LDE-paclitaxel and 20 in placebo group were enrolled.

Coronary Artery Disease 59

Coronary Artery Disease Laboratory Plaque Myocardial Infarction 59

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

The models were mainly constructed using data from individuals diagnosed with ST-segment elevation myocardial infarction (STEMI). The commonly used predictor variables include LVEF, age, Killip classification, diabetes, and various others.

Myocardial Infarction 59

Myocardial Infarction STEMI Article Diabetes 59